THE DEAL, AT A GLANCE
From the announcementDecibel Therapeutics
01Who is involvedBacked by VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedDecibel Therapeutics raised $75M Series CFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersDecibel Therapeutics is using Series C capital to advance DB-OTO and AAV-based hearing restoration toward approval in hearing loss and vestibular conditions.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Decibel Therapeutics · Financing Record
Explore source-linked visual explanations for Decibel Therapeutics. Unsupported claims are withheld while source review continues.
Record 946 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →